Big Pharma expands into home testing

At-home tests, once considered an anomaly, became de rigueur during the COVID-19 pandemic. Now, as COVID-19 testing rates decline from their pandemic peak, diagnostic companies businesses are seeing an opportunity in direct-to-consumer testing.

“Never before has the general population been more aware of in vitro diagnostics and the relevance of our industry than in the last two years with COVID-19,” said Jenna Urquhart, head of new franchise business development for Siemens Healthineers, “Thanks to the prevalence of rapid antigen tests, people have learned that it is possible to collect a sample, run a test, and receive results in minutes, all in the comfort of their own homes.”

Four of the largest diagnostics firms surveyed by MedTech Dive said they plan to continue offering COVID-19 testing and will add other types of at-home tests. Some companies said they see an opportunity in detecting other infectious diseases, while others expect increasing demand from patients managing chronic health conditions.

To read more, CLICK HERE.

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).

Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags